Schertenleib Avocats

Schertenleib Avocats is a boutique firm known for patent litigation in France in high-technology matters and life sciences. Casework recurrently features cross-border litigation for leading multinationals invested in complex IP mandates. In the life sciences, it advises on supplementary protection certificates, regulatory law and data protection. Partner Denis Schertenleib leads with Ombeline Degreze-Pechade.

2023

"The team is great to work with in many ways – expertise and results-oriented work, provides clear recommendations and advice, quick attention to our matters. It is a real team feeling; they are invested in our success together."

"They are clever, quick and client-centric."

"They are very knowledgeable and experienced in patent matters with a great team spirit. They provided very reliable advice when asked. Very trustworthy."

The firm successfully represented Mylan in preliminary injunction proceedings against Allergan relating to the blockbuster drug Bimatoprost. It also represented Mylan in its revocation action against the supplementary protection certificate held by Gilead Sciences on Truvada.